BSE filing, NSE: RAAJMEDI. Summary written from the filing by ALFA Finder's alert engine.
Raaj Medisafe India Ltd: key numbers
- Share price
- ₹102.99
- Market cap
- ₹135.4 Cr
- Revenue (annual)
- ₹80.01 Cr
- Net profit (annual)
- ₹1.81 Cr
- P/E (TTM)
- 57.2×Sector 51.1×
- Promoter holding
- 59.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raaj Medisafe India Ltd
All →Raaj Medisafe India Other Announcement
Raaj Medisafe India Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This routine compliance filing details the company's shareholding structure for the quarter.
Raaj Medisafe India Annual General Meeting
Raaj Medisafe India Ltd held its 41st Annual General Meeting on September 21, 2026, where members approved financial statements, director appointments, and related party transactions.
Raaj Medisafe India Promoter Selling (Off-Market)
Brahma Swaroop Jajoo (Promoter) gifted 1,94,700 shares (1.19% stake) of Raaj Medisafe India Ltd to Vishnu Jajoo HUF in an off-market inter-se transfer.
Raaj Medisafe India Promoter Buying (Off-Market)
Promoter group entities transferred 2,21,693 equity shares (1.35% stake) of Raaj Medisafe India Ltd to Vishnu Jajoo HUF via an off-market inter-se gift transaction.
Raaj Medisafe India Bags ₹17.02 Cr Order
Raaj Medisafe India Limited secured a Rs. 17.02 Crore contract from Madhya Pradesh Public Health Services Corporation Limited for supplying baby diapers to government hospitals.
- Value
- ₹17.02 Cr
- Execution
- Within 18 months
Raaj Medisafe India Annual General Meeting
Raaj Medisafe India Limited has submitted its Annual Report for FY 2025-26. The 41st Annual General Meeting is scheduled for September 21, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.